“Seeing the current market situation, we would advise investors to invest in Bharat ETF Bond for the long term because the return is predictable and also earlier bonds have delivered annualised return in the range of 14-18 percent. Additionally, it has a high credit rating and a good tool for diversification into debt,” Ajit Mishra, VP - Research, Religare Broking told Moneycontrol. … [Read more...] about Rossari Biotech IPO, Bharat Bond ETF & Yes Bank FPO: Where should investors put their money?
Best sports betting podcast
These numbers (returns and SD) are the outcome of actions taken by the fund manager in the past. If you change the time period under observation, the numbers would be different. Understand how a scheme’s SD has changed over a period of time, as fund managers can change the composition of their portfolios. … [Read more...] about How reliable is standard deviation in gauging a fund’s volatility?
Specialty chemicals manufacturer Rossari Biotech has become the first company to launch an initial public offering (IPO) during the coronavirus lockdown and the second after SBI Cards this year. The company was to launch its IPO in March but unfavourable market conditions forced it to put off the plan. … [Read more...] about Analysts say subscribe to Rossari Biotech IPO despite high valuation, here is why